{"url_path":"/sec/ensc/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1716947/0001493152-26-023811-index.html","accession_number":"0001493152-26-023811","cik":"0001716947","ticker":"ENSC","issuer_name":"Ensysce Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1716947/0001493152-26-023811-index.html","primary_entity_key":"0001716947","primary_entity_name":"Ensysce Biosciences, Inc."},"word_count":235,"has_tables":true,"body_markdown":"**Item\n6. Exhibits.**\n\n \n\nThe\nfollowing exhibits are filed as part of this report:\n\n \n\n**Exhibit**\n\n**Number**\n\n \n**Description**\n\n31.1*\n \n[Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-1.htm)\n\n31.2*\n \n[Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-2.htm)\n\n32.1*\n \n[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm)\n\n32.2*\n \n[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-2.htm)\n\n101.INS\n \nInline\nXBRL Instance Document\n\n101.SCH\n \nInline\nXBRL Taxonomy Extension Schema Document\n\n101.CAL\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n*\nFiled herewith.\n\n31\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned, thereunto duly authorized.\n\n \n\n \n**ENSYSCE\nBIOSCIENCES, INC.**\n\n \n \n\nDate:\nMay 15, 2026\n*/s/\nDavid Humphrey*\n\n \nDavid\nHumphrey\n\n \nChief\nFinancial Officer, Secretary and Treasurer\n\n \n\n32"}